The Vanguard Group 13D and 13G filings for AbbVie Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 4:55 pm Purchase |
2023-12-29 | 13G | AbbVie Inc. ABBV |
The Vanguard Group | 160,380,057 9.080% |
2,062,505 (+1.30%) |
Filing |
| 2023-02-09 10:54 am Purchase |
2022-12-30 | 13G | AbbVie Inc. ABBV |
The Vanguard Group | 158,317,552 8.950% |
12,005,483 (+8.21%) |
Filing |
| 2022-02-09 3:15 pm Purchase |
2021-12-31 | 13G | AbbVie Inc. ABBV |
The Vanguard Group | 146,312,069 8.280% |
3,748,995 (+2.63%) |
Filing |
| 2021-02-10 10:30 am Purchase |
2020-12-31 | 13G | AbbVie Inc. ABBV |
The Vanguard Group | 142,563,074 8.080% |
19,988,354 (+16.31%) |
Filing |